[1]
M. Arora, D. Ram, and S. K. Praharaj, “CHANGES IN URINARY MONOAMINE METABOLITES WITH ANTIPSYCHOTIC TREATMENT IN SCHIZOPHRENIA”, Asian J Pharm Clin Res, vol. 8, no. 5, pp. 110–114, Sep. 2015.